in Newswire March 17, 2020

Inovio Pharmaceuticals Hit with Securities Class Action Over False Claims of Developing COVID-19 Vaccine

by Corrado Rizzi

Last Updated on March 17, 2020

McDermid v. Inovio Pharmaceuticals, Inc. et al.

Filed: March 12, 2020 § 2:20-cv-01402

A class action says Inovio Pharmaceuticals stockholders were injured when it was revealed that the company, despite its claims, had not developed a COVID-19 vaccine.



Last Updated on March 17, 2020 — 3:03 PM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.